Union Inks China Deal For Promising Skin Drug Orismilast

A Potential Rival To Amgen's Otezla

Dermatitis
• Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business